[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @AaronRosenblum5 Aaron Rosenblum, PhD, former CFA (fuck dues) Aaron Rosenblum, PhD, former CFA (fuck dues) posts on X about liquidity, holders, $calc, into the the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1203443353339060225/interactions)  - X Week XXXXX +83% - X Month XXXXXX +16% - X Months XXXXXXX +285% - X Year XXXXXXX +54% ### Mentions: XX [#](/creator/twitter::1203443353339060225/posts_active)  - X Week XX no change - X Month XX -XX% - X Months XXX +99% - X Year XXX +47% ### Followers: XXXXX [#](/creator/twitter::1203443353339060225/followers)  - X Week XXXXX +0.44% - X Month XXXXX +2% - X Months XXXXX +49% - X Year XXXXX +69% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1203443353339060225/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) [musicians](/list/musicians) **Social topic influence** [liquidity](/topic/liquidity) #3574, [holders](/topic/holders), [$calc](/topic/$calc), [into the](/topic/into-the), [ready to fight](/topic/ready-to-fight), [build a](/topic/build-a), [lack of](/topic/lack-of), [bear market](/topic/bear-market), [sentiment](/topic/sentiment), [guess](/topic/guess) ### Top Social Posts Top posts by engagements in the last XX hours "@DeepSouthDoctor @jfais20 @Kapstahoon @BalaBioResearch did Substack article tearing them up. Link is in his bio" [X Link](https://x.com/AaronRosenblum5/status/1999560119760105926) 2025-12-12T19:20Z 2994 followers, XXX engagements "@bingbingbom Has to have leaked. Price action makes no sense otherwise" [X Link](https://x.com/AaronRosenblum5/status/1999113011630358623) 2025-12-11T13:44Z 2997 followers, 1544 engagements "@Vulpescap None of those secondary endpoints are possible based on the n's given. That is my biggest concern with the dataset that they might literally be faking it" [X Link](https://x.com/AaronRosenblum5/status/2000925071674892740) 2025-12-16T13:44Z 2997 followers, 1184 engagements "@Sanctuary_Bio Vtgn still pending" [X Link](https://x.com/AaronRosenblum5/status/2001045603430666463) 2025-12-16T21:43Z 2996 followers, XXX engagements "@BayAreaBiotechI And a shitload of warrant holders looking for exit liquidity" [X Link](https://x.com/AaronRosenblum5/status/2001287939074977951) 2025-12-17T13:46Z 2996 followers, XXX engagements "$calc is an under the radar name that offers a very interesting opportunity here. They have decent-good probability of success in their Kourage trial and extreme upside potential if they get a clean win. I will dig into the past data and explain why the opportunity exists. 🧵1/12" [X Link](https://x.com/AaronRosenblum5/status/2001345385756074197) 2025-12-17T17:34Z 3000 followers, 4150 engagements "She said co was ready to fight at last fda meeting so pleasantly surprised when fda was on board with everything they prev didn't like. For aki it is through cardio renal and she said they are on board as well. 8/12" [X Link](https://x.com/AaronRosenblum5/status/2001345406765302083) 2025-12-17T17:35Z 3000 followers, XXX engagements "Now that I have discussed the data that I think justifies why there is a reasonable probability of success I will discuss why I think the opportunity exists. They went public through a reverse merger in 2023 and are pretty tightly held by venture funds. 9/12" [X Link](https://x.com/AaronRosenblum5/status/2001345409277689942) 2025-12-17T17:35Z 3000 followers, XXX engagements "They did a pipe and a small offering in 2024 but the liquidity has just not been there for anyone who wants to build a sizable position. The missed primary lack of reg alignment for AP and overall bear market were also sig factors that prevented real interest. 10/12" [X Link](https://x.com/AaronRosenblum5/status/2001345411194429824) 2025-12-17T17:35Z 3000 followers, XXX engagements "Given the current macro env/biotech sentiment they should be able to raise the capital to fund both AKI and AP at a valuation well above the current one if they hit XX% relative mortality benefit (bar co set for clin relevance) even if miss stat sig. 11/12" [X Link](https://x.com/AaronRosenblum5/status/2001345413132193985) 2025-12-17T17:35Z 3000 followers, 1014 engagements "@BoitechB @no_liquidity @john_hersc79276 They are taking pdl1v to 1l hnscc stupidly. My guess is due to the sunk cost fallacy and need to feel like they earned a return on the deal" [X Link](https://x.com/AaronRosenblum5/status/2001348888993894578) 2025-12-17T17:48Z 3000 followers, XXX engagements "@Driller562 @BiotechDodo Is a nothingburger unless fda changes its mind on ped rare diz designation. CEO said they have more n and data basically looks the same but will not be pursuing it internally unless fda changes their mind" [X Link](https://x.com/AaronRosenblum5/status/2001374974876225888) 2025-12-17T19:32Z 3000 followers, XXX engagements "@ElMonoGran42994 @SiriusStarCapi1 Its a meh drug in mm that doesnt have much place in evolving competitive landscape with car t and bispecifics. If mf hits on both endpoints it will be soc and a for sure blockbuster. Def high risk but prior data while small n was very strong" [X Link](https://x.com/AaronRosenblum5/status/2001605797692768305) 2025-12-18T10:49Z 2999 followers, XX engagements "@BayAreaBiotechI They were too aggressive in dosing and terrible in execution. They were guiding to multiple n=20 cohorts and instead we got X new patients in mono that were efficacy evaluable. I think they have a drug with a therapeutic index but not sure they have the cash/time to show it" [X Link](https://x.com/AaronRosenblum5/status/2001652704352096428) 2025-12-18T13:56Z 3000 followers, XXX engagements "@Jul05310473John @BayAreaBiotechI momentum is dead but prob worth a go into their update as well. Prob gunna be equally as binary with cash pretty low (as burn increases with obesity trial) by the time they get to the update" [X Link](https://x.com/AaronRosenblum5/status/2001661112207425848) 2025-12-18T14:29Z 3000 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@AaronRosenblum5 Aaron Rosenblum, PhD, former CFA (fuck dues)
Aaron Rosenblum, PhD, former CFA (fuck dues) posts on X about liquidity, holders, $calc, into the the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +83%
- X Month XXXXXX +16%
- X Months XXXXXXX +285%
- X Year XXXXXXX +54%
Mentions: XX #
- X Week XX no change
- X Month XX -XX%
- X Months XXX +99%
- X Year XXX +47%
Followers: XXXXX #
- X Week XXXXX +0.44%
- X Month XXXXX +2%
- X Months XXXXX +49%
- X Year XXXXX +69%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence finance musicians
Social topic influence liquidity #3574, holders, $calc, into the, ready to fight, build a, lack of, bear market, sentiment, guess
Top Social Posts
Top posts by engagements in the last XX hours
"@DeepSouthDoctor @jfais20 @Kapstahoon @BalaBioResearch did Substack article tearing them up. Link is in his bio"
X Link 2025-12-12T19:20Z 2994 followers, XXX engagements
"@bingbingbom Has to have leaked. Price action makes no sense otherwise"
X Link 2025-12-11T13:44Z 2997 followers, 1544 engagements
"@Vulpescap None of those secondary endpoints are possible based on the n's given. That is my biggest concern with the dataset that they might literally be faking it"
X Link 2025-12-16T13:44Z 2997 followers, 1184 engagements
"@Sanctuary_Bio Vtgn still pending"
X Link 2025-12-16T21:43Z 2996 followers, XXX engagements
"@BayAreaBiotechI And a shitload of warrant holders looking for exit liquidity"
X Link 2025-12-17T13:46Z 2996 followers, XXX engagements
"$calc is an under the radar name that offers a very interesting opportunity here. They have decent-good probability of success in their Kourage trial and extreme upside potential if they get a clean win. I will dig into the past data and explain why the opportunity exists. 🧵1/12"
X Link 2025-12-17T17:34Z 3000 followers, 4150 engagements
"She said co was ready to fight at last fda meeting so pleasantly surprised when fda was on board with everything they prev didn't like. For aki it is through cardio renal and she said they are on board as well. 8/12"
X Link 2025-12-17T17:35Z 3000 followers, XXX engagements
"Now that I have discussed the data that I think justifies why there is a reasonable probability of success I will discuss why I think the opportunity exists. They went public through a reverse merger in 2023 and are pretty tightly held by venture funds. 9/12"
X Link 2025-12-17T17:35Z 3000 followers, XXX engagements
"They did a pipe and a small offering in 2024 but the liquidity has just not been there for anyone who wants to build a sizable position. The missed primary lack of reg alignment for AP and overall bear market were also sig factors that prevented real interest. 10/12"
X Link 2025-12-17T17:35Z 3000 followers, XXX engagements
"Given the current macro env/biotech sentiment they should be able to raise the capital to fund both AKI and AP at a valuation well above the current one if they hit XX% relative mortality benefit (bar co set for clin relevance) even if miss stat sig. 11/12"
X Link 2025-12-17T17:35Z 3000 followers, 1014 engagements
"@BoitechB @no_liquidity @john_hersc79276 They are taking pdl1v to 1l hnscc stupidly. My guess is due to the sunk cost fallacy and need to feel like they earned a return on the deal"
X Link 2025-12-17T17:48Z 3000 followers, XXX engagements
"@Driller562 @BiotechDodo Is a nothingburger unless fda changes its mind on ped rare diz designation. CEO said they have more n and data basically looks the same but will not be pursuing it internally unless fda changes their mind"
X Link 2025-12-17T19:32Z 3000 followers, XXX engagements
"@ElMonoGran42994 @SiriusStarCapi1 Its a meh drug in mm that doesnt have much place in evolving competitive landscape with car t and bispecifics. If mf hits on both endpoints it will be soc and a for sure blockbuster. Def high risk but prior data while small n was very strong"
X Link 2025-12-18T10:49Z 2999 followers, XX engagements
"@BayAreaBiotechI They were too aggressive in dosing and terrible in execution. They were guiding to multiple n=20 cohorts and instead we got X new patients in mono that were efficacy evaluable. I think they have a drug with a therapeutic index but not sure they have the cash/time to show it"
X Link 2025-12-18T13:56Z 3000 followers, XXX engagements
"@Jul05310473John @BayAreaBiotechI momentum is dead but prob worth a go into their update as well. Prob gunna be equally as binary with cash pretty low (as burn increases with obesity trial) by the time they get to the update"
X Link 2025-12-18T14:29Z 3000 followers, XXX engagements